Drugs for HER-2-positive breast cancer

Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best described membrane receptor tyrosine kinase family in malignant tumors. With implementation of the growth-inhibitory...

Descripció completa

Dades bibliogràfiques

Publicat a:	Springer eBooks.
Autor corporatiu:	SpringerLink (Online service)
Altres autors:	Sibilia, Maria, Zielinski, Christoph C., Bartsch, Rupert, Grunt, Thomas W.
Format:	Electronic Resource
Idioma:	English
Publicat:	Basel Springer Basel c2011.
Matèries:	Medicine. Oncology. Immunology. Electronic books.
Accés en línia:	Available for University of the Philippines Diliman via SpringerLink. Click here to access